Innovative Tissue Processing
Thanks to our commitment to research and development, RTI’s innovations continuously raise the bar of science and safety in the allograft industry — from being the first company to offer precision-tooled bone implants, to inventing fully validated sterilization processes that include viral inactivation steps, to being the first company to offer assembled allograft technology.
RTI’s investment in research and development initiatives has resulted in advanced innovations that enable more and more recipients to benefit from the priceless gift of tissue donation.
Osteoinductivity (OI) testing
Surgeons routinely use demineralized bone matrix (DBM) implants as a bone void filler to assist in repairing defects or reconstructing bone damaged by trauma or disease. OI potential is verified by 100 percent lot testing after sterilization.
New implant technology
Since offering the first precision-shaped allograft implant in 1996, RTI is continuously evolving allograft implants in an effort to make them easier for surgeons to use, to garner positive surgical outcomes and to maximize each gift of donation to help more recipients.